Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Francoise de Vassal"'
Autor:
Emma Goldschmidt, Jean-Pierre Lotz, Michel Delgado, J. Gastiaburu, Patricia Ribaud, Haim Tapiero, Léon Schwarzenberg, Jean-Louis Misset, Reginal Hulhoven, Georges Mathé, Francoise de Vassal, D. Machover, Manuel Benavides
Publikováno v:
European Journal of Haematology. 38:33-42
SUMMARY Aclarubicin (ACM) was administered as induction treatment to 38 evaluable patients with acute myeloid leukaemia (AML) who were either refractory to initial chemotherapy or in relapse. Thirteen patients received daily doses of ACM while the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ec560fb75d41504e0e6449d8261fd3
https://doi.org/10.1111/j.1600-0609.1987.tb00020.x
https://doi.org/10.1111/j.1600-0609.1987.tb00020.x
Autor:
Schwarzenberg L, J.L. Misset, Henry Rappaport, Guy Lemaigre, Thierry Dorval, Francoise de Vassal, E. Goldschmidt, Héléne Gaget, D. Machover, Georges Mathé, Patricia Ribaud
Publikováno v:
Cancer. 53:1644-1650
The authors developed a therapeutic regimen in which 33 patients aged 11 to 61 years (mean +/- SE, 35.9 +/- 2.3 years) with acute myeloid leukemia (AML) were given intensive induction chemotherapy with Adriamycin (doxorubicin) (ADM), vincristine (VCR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47fccd0ee08c1ee4b87648f43e0cd7bd
https://doi.org/10.1002/1097-0142(19840415)53:8<1644::aid-cncr2820530804>3.0.co
https://doi.org/10.1002/1097-0142(19840415)53:8<1644::aid-cncr2820530804>3.0.co